Hideyasu Murakami

779 total citations
15 papers, 647 citations indexed

About

Hideyasu Murakami is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health. According to data from OpenAlex, Hideyasu Murakami has authored 15 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Pediatrics, Perinatology and Child Health and 5 papers in Psychiatry and Mental health. Recurrent topics in Hideyasu Murakami's work include Drug Transport and Resistance Mechanisms (12 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Epilepsy research and treatment (5 papers). Hideyasu Murakami is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Epilepsy research and treatment (5 papers). Hideyasu Murakami collaborates with scholars based in Japan, France and Ireland. Hideyasu Murakami's co-authors include Yasufumi Sawada, Hisakazu Ohtani, Noriko Koyabu, Masayuki Tsujimoto, Hitomi Takanaga, Hirotami Matsuo, Hiroki Satoh, Takeshi Uchiumi, Michihiko Kuwano and Takanori Nakamura and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, International Journal of Pharmaceutics and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Hideyasu Murakami

15 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideyasu Murakami Japan 12 350 225 170 89 79 15 647
Carolina I. Ghanem Argentina 15 230 0.7× 116 0.5× 233 1.4× 154 1.7× 64 0.8× 25 685
Akiko Soyama Japan 22 370 1.1× 131 0.6× 511 3.0× 287 3.2× 81 1.0× 32 1.1k
Heidi L. Liston United States 10 183 0.5× 194 0.9× 202 1.2× 100 1.1× 126 1.6× 12 712
Eike Schroeder Germany 7 598 1.7× 391 1.7× 125 0.7× 98 1.1× 55 0.7× 8 825
Emma L. Stanley United Kingdom 6 123 0.4× 125 0.6× 242 1.4× 247 2.8× 28 0.4× 6 648
P d'Athis France 17 90 0.3× 284 1.3× 79 0.5× 97 1.1× 93 1.2× 48 752
C von Bahr Sweden 11 122 0.3× 100 0.4× 244 1.4× 165 1.9× 67 0.8× 22 555
Xiu-Lin Huang Japan 10 331 0.9× 189 0.8× 71 0.4× 124 1.4× 49 0.6× 18 552
David L. Bourdet United States 14 317 0.9× 160 0.7× 194 1.1× 182 2.0× 75 0.9× 37 821
R H Lévy United States 19 328 0.9× 674 3.0× 520 3.1× 143 1.6× 138 1.7× 33 1.3k

Countries citing papers authored by Hideyasu Murakami

Since Specialization
Citations

This map shows the geographic impact of Hideyasu Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyasu Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyasu Murakami more than expected).

Fields of papers citing papers by Hideyasu Murakami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyasu Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyasu Murakami. The network helps show where Hideyasu Murakami may publish in the future.

Co-authorship network of co-authors of Hideyasu Murakami

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyasu Murakami. A scholar is included among the top collaborators of Hideyasu Murakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyasu Murakami. Hideyasu Murakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Tsujimoto, Masayuki, et al.. (2007). Effect of macrolide antibiotics on uptake of digoxin into rat liver. Biopharmaceutics & Drug Disposition. 28(3). 113–123. 10 indexed citations
2.
Murakami, Yûichi, Tomoaki Tanaka, Hideyasu Murakami, et al.. (2006). Pharmacokinetic modelling of the interaction between St John’s wort and ciclosporin A. British Journal of Clinical Pharmacology. 61(6). 671–676. 11 indexed citations
3.
Ohtani, Hisakazu, Noriko Koyabu, Fumihiko Ushigome, et al.. (2006). Inhibitory effects of angiotensin II receptor antagonists and leukotriene receptor antagonists on the transport of human organic anion transporter 4. Journal of Pharmacy and Pharmacology. 58(11). 1499–1505. 23 indexed citations
4.
Murakami, Hideyasu, Hitomi Takanaga, Hirotami Matsuo, et al.. (2005). Functional characterization of adenosine transport across the BBB in mice. International Journal of Pharmaceutics. 290(1-2). 37–44. 15 indexed citations
5.
Satoh, Hiroki, Masayuki Tsujimoto, Hideyasu Murakami, et al.. (2005). CITRUS JUICES INHIBIT THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B. Drug Metabolism and Disposition. 33(4). 518–523. 185 indexed citations
6.
Ohtani, Hisakazu, Masayuki Tsujimoto, Hideyasu Murakami, et al.. (2005). Functional Analysis of Organic Cation Transporter 3 Expressed in Human Placenta. Journal of Pharmacology and Experimental Therapeutics. 315(2). 888–895. 93 indexed citations
7.
Ohtani, Hisakazu, et al.. (2004). INHIBITORY EFFECTS OF POMELO ON THE METABOLISM OF TACROLIMUS AND THE ACTIVITIES OF CYP3A4 AND P-GLYCOPROTEIN. Drug Metabolism and Disposition. 32(8). 828–833. 48 indexed citations
8.
Tsujikawa, Kenji, Hitoshi Sato, Yasuhiko Yamada, et al.. (2003). Potentiation of domperidone‐induced catalepsy by a P‐glycoprotein inhibitor, cyclosporin A. Biopharmaceutics & Drug Disposition. 24(3). 105–114. 25 indexed citations
9.
Murakami, Hideyasu, et al.. (2002). Distribution of domperidone into the rat brain is increased by brain ischaemia or treatment with the P-glycoprotein inhibitor verapamil. Journal of Pharmacy and Pharmacology. 54(5). 729–733. 20 indexed citations
10.
Yamamoto, Chika, Hideyasu Murakami, Noriko Koyabu, et al.. (2002). Contribution of P-glycoprotein to efflux of ramosetron, a 5-HT3 receptor antagonist, across the blood-brain barrier. Journal of Pharmacy and Pharmacology. 54(8). 1055–1063. 26 indexed citations
11.
Murakami, Hideyasu, et al.. (2000). Characteristics of Choline Transport Across the Blood-Brain Barrier in Mice: Correlation with In Vitro Data. Pharmaceutical Research. 17(12). 1526–1530. 28 indexed citations
12.
Takanaga, Hitomi, Ayako Ohnishi, Hirotami Matsuo, et al.. (2000). Pharmacokinetic analysis of felodipine–grapefruit juice interaction based on an irreversible enzyme inhibition model. British Journal of Clinical Pharmacology. 49(1). 49–58. 46 indexed citations
13.
Murakami, Hideyasu, Hitomi Takanaga, Hirotami Matsuo, Hisakazu Ohtani, & Yasufumi Sawada. (2000). Comparison of blood-brain barrier permeability in mice and rats using in situ brain perfusion technique. American Journal of Physiology-Heart and Circulatory Physiology. 279(3). H1022–H1028. 87 indexed citations
14.
Koyabu, Noriko, Hitomi Takanaga, Hideyasu Murakami, et al.. (1999). UPTAKE AND EFFLUX TRANSPORT MECHANISMS OF TOLBUTAMIDE ACROSS THE BLOOD-BRAIN BARRIER. Drug Metabolism and Pharmacokinetics. 14(supplement). 108–109. 2 indexed citations
15.
Takanaga, Hitomi, Hideyasu Murakami, Noriko Koyabu, et al.. (1998). Efflux Transport of Tolbutamide Across the Blood-brain Barrier. Journal of Pharmacy and Pharmacology. 50(9). 1027–1033. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carolina I. Ghanem Breakdown of academic impact, for papers by Akiko Soyama Breakdown of academic impact, for papers by Heidi L. Liston Breakdown of academic impact, for papers by Eike Schroeder Breakdown of academic impact, for papers by Emma L. Stanley Breakdown of academic impact, for papers by P d'Athis Breakdown of academic impact, for papers by C von Bahr Breakdown of academic impact, for papers by Xiu-Lin Huang Breakdown of academic impact, for papers by David L. Bourdet Breakdown of academic impact, for papers by R H Lévy
Rankless by CCL
2026